This topic contains a solution. Click here to go to the answer

Author Question: F is a ratio of A) within-groups variation divided by between-groups variation. B) ... (Read 92 times)

tatyanajohnson

  • Hero Member
  • *****
  • Posts: 569
F is a ratio of
 
  A) within-groups variation divided by between-groups variation.
  B) between-groups variation divided by within-groups variation.
  C) external validity divided by internal validity.
  D) internal validity divided by external validity.

Question 2

The numerator of the F-test reflects
 
  A) experimental, extraneous, and error variance.
  B) experimental and extraneous variance.
  C) error variance only.
  D) experimental variance.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ebe

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Answer: B

Answer to Question 2

Answer: A





 

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library